Go Symbol Lookup
Loading...

Charles River Laboratories International Inc

More

  • RESEARCH ALERT-Mersen: HSBC cuts target price Tuesday, 7 May 2013 | 2:27 AM ET

    *HSBC cuts target price to 20 euros from 20.50 euros; rating neutral. For a summary of rating actions and price target changes on European companies:. Reuters Station users, click. 1580.

  • *Exane BNP Paribas cuts price target by 13 percent to 20 euros; rating neutral. For a summary of rating actions and price target changes on European companies:. Reuters Station users, click. 1580.

  • Biopharma Play That May Bypass FDA Roulette Wednesday, 9 Jan 2013 | 6:28 PM ET
    In this May 21, 2012, photo, a dealer at Revel prepares for another round of roulette at the Atlantic City, N.J., casino as patrons await the result. Revel won $14.9 million from gamblers in June, its third month of operation, keeping it mired in eighth place out of Atlantic City's 12 casinos in terms of gambling revenue. (AP Photo/Wayne Parry)

    Is there a way to profit from small cap biotech without being at the mercy of the FDA's drug approval process? Maybe.